Three-year data from ongoing open-label study supported safety and effectiveness of seladelpar in patients with primary biliary cholangitis.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/seladelpar-staves-liver-stiffness-primary-biliary-2025a1000v4y?src=rss
Author :
Publish date : 2025-11-10 17:48:00
Copyright for syndicated content belongs to the linked Source.
